Hospital Galdakao-Usansolo
osakidetza.euskadi.eusTotal trials
30
Active
0
Phase 3
1
Total enrollment
1,393,275
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Heart Failure4
- COVID-192
- Colorectal Cancer2
- Colonoscopy2
- COPD2
- Community Acquired Pneumonia1
- Postoperative Complications1
- Risk Factors1
Frequently asked questions about Hospital Galdakao-Usansolo
- How many clinical trials does Hospital Galdakao-Usansolo have on ClinicalTrials.gov?
- Hospital Galdakao-Usansolo is listed as the lead sponsor on 30 clinical trials in ClinicalTrials.gov, 0 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Hospital Galdakao-Usansolo's trials are in Phase 3?
- 1 of Hospital Galdakao-Usansolo's trials are in Phase 3.
- What therapeutic areas does Hospital Galdakao-Usansolo focus on?
- Hospital Galdakao-Usansolo's most-studied conditions on ClinicalTrials.gov are Heart Failure, COVID-19, Colorectal Cancer, Colonoscopy, COPD.